RepublicanBill · H.R. 6624· House(119-HR-6624)

Biological Intellectual Property Protection Act of 2025

Rep. Davidson
Age: 56 years
Ohio
Introduced
12/11/2025
Last activity
4/22/2026 — Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.
Sponsored by
Warren Davidson
Cosponsors
Republican - 8Democrat - 3
International Affairs
  1. Introduced

What this bill would do

The Biological Intellectual Property Protection Act of 2025 aims to restrict the export of United States intellectual property and sensitive information regarding synthetic biology to foreign entities of concern. The bill seeks to address concerns regarding the People's Republic of China's efforts to access sensitive data to modernize its military and intelligence capabilities. To prevent this, the act amends the Export Control Reform Act of 2018. It establishes a requirement for a license to export digital sequences of synthetic DNA or RNA designed by humans or artificial intelligence. This regulation targets transfers to foreign entities of concern to protect national security and intellectual property.

Yes· 3 of 4

  • Does this make patent and copyright rules fairer?+5

    The bill provides stronger protections for United States intellectual property regarding synthetic DNA and RNA sequences.

  • Does this give the federal government more power?+3

    The bill expands federal authority by requiring the Secretary to oversee and license the export of specific biological digital sequences.

  • Does this better protect the country from computer attacks?+3

    The bill protects sensitive digital genetic sequences from being exploited by foreign adversaries to modernize their military capabilities.

The opposite

  • Would business owners be better off under this?-3

    Biotechnology business owners will face new regulatory hurdles and licensing requirements for exporting digital sequences.

  • Does this make it easier to run a small business?-2

    The bill imposes new licensing requirements on the export of synthetic biology digital sequences which may increase regulatory burdens for biotechnology firms.

  • Does this make trade with other countries easier?-2

    The bill adds export licensing requirements that could restrict the movement of biotechnology information across borders.